Three-year outcomes of a phase II study of adjuvant chemotherapy with S-1 plus docetaxel for stage III gastric cancer after curative D2 gastrectomy

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

(2012) Yung-Jue Bang et al.   LANCET

Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer

(2011) Mitsuru Sasako et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase II Feasibility Study of Adjuvant S-1 plus Docetaxel for Stage III Gastric Cancer Patients after Curative D2 Gastrectomy

(2011) Shigeyuki Tamura et al.   ONCOLOGY

Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer

(2010) D. Takahari et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Risks From Antipsychotic Medications in Children and Adolescents

(2010) Adam B. Lewin   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

(2008) Wasaburo Koizumi et al.   LANCET ONCOLOGY